FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy.
Cannell IG, Sawicka K, Pearsall I, Wild SA, Deighton L, Pearsall SM, Lerda G, Joud F, Khan S, Bruna A, Simpson KL, Mulvey CM, Nugent F, Qosaj F, Bressan D; CRUK IMAXT Grand Challenge Team; Dive C, Caldas C, Hannon GJ.
Cannell IG, et al. Among authors: sawicka k.
Cell Rep. 2023 Aug 29;42(8):112791. doi: 10.1016/j.celrep.2023.112791. Epub 2023 Jul 26.
Cell Rep. 2023.
PMID: 37499655
Free article.